{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:01:13Z","timestamp":1778274073513,"version":"3.51.4"},"reference-count":113,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:00:00Z","timestamp":1411430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40620-014-0142-4","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T03:31:59Z","timestamp":1411356719000},"page":"415-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool"],"prefix":"10.1093","volume":"28","author":[{"given":"A.","family":"Galassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cupisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"issue":"Suppl 3","key":"142_CR1","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(Suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 113","key":"142_CR2","first-page":"S50","volume":"76","author":"KDIGO","year":"2009","unstructured":"KDIGO (2009) Treatment of CKD\u2013MBD targeted at lowering high serum phosphorus and maintaining serum calcium. Kidney Int 76(Suppl 113):S50\u2013S59","journal-title":"Kidney Int"},{"issue":"11","key":"142_CR3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119\u20131127","journal-title":"JAMA"},{"key":"142_CR4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJMc0800696","volume":"359","author":"M Cirillo","year":"2008","unstructured":"Cirillo M, Ciacci C, de Santo NG (2008) Age renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 359:864\u2013866","journal-title":"N Engl J Med"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11914-013-0178-8","volume":"11","author":"M Pi","year":"2013","unstructured":"Pi M, Quarles D (2013) Novel bone endocrine networks integrating mineral and energy metabolism. Curr Osteoporos Rep 11:391\u2013399","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"142_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.ajkd.2013.07.012","volume":"63","author":"D Zhang","year":"2014","unstructured":"Zhang D, Maalouf NM, Adams-Huet B et al (2014) Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross sectional study of the national health and nutrition examination survey (NHANES) 2003\u20132006. Am J Kidney Dis 63(2):198\u2013205","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"142_CR7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1517\/14656566.2012.730520","volume":"13","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino M, Bruschetta E, Cusi D et al (2012) Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate. Expert Opin Pharmacother 13(16):2337\u20132353","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"142_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1525-139X.2007.00309.x","volume":"20","author":"J Uribarri","year":"2007","unstructured":"Uribarri J (2007) Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20(4):295\u2013301","journal-title":"Semin Dial"},{"key":"142_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000245640","volume":"29","author":"M Kuhlmann","year":"2010","unstructured":"Kuhlmann M (2010) Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purifi 29:137\u2013144","journal-title":"Blood Purifi"},{"key":"142_CR10","first-page":"144","volume-title":"Health and disease","author":"LH Allen","year":"1994","unstructured":"Allen LH, Wood RJ (1994) Calcium and phosphorus in modern nutrition. In: Shils ME, Olson JA, Shike M (eds) Health and disease, 8th edn. Lea & Febiger, Philadelphia, pp 144\u2013163","edition":"8"},{"key":"142_CR11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1986.252","volume":"30","author":"JA Ramirez","year":"1986","unstructured":"Ramirez JA, Emmett M, White MG et al (1986) The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30:753\u2013795","journal-title":"Kidney Int"},{"key":"142_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.nutr.25.050304.092642","volume":"25","author":"HS Tenenhouse","year":"2005","unstructured":"Tenenhouse HS (2005) Regulation of phosphate homeostasis by the type IIaNa\/phosphate cotransporter. Ann Rev Nutr 25:197\u2013214","journal-title":"Ann Rev Nutr"},{"key":"142_CR13","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","volume":"189","author":"TJ Bernd","year":"2005","unstructured":"Bernd TJ, Schiavi S, Kumar R et al (2005) \u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol 189:F1170\u2013F1182","journal-title":"Am J Physiol Renal Physiol"},{"key":"142_CR14","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","volume":"91","author":"DM Antoniucci","year":"2006","unstructured":"Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91:3144\u20133149","journal-title":"J Clin Endocrinol Metab"},{"key":"142_CR15","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.ki.5002163","volume":"71","author":"PU Torres","year":"2007","unstructured":"Torres PU, Prie\u2019 D, Molina Bl\u00e8try V et al (2007) Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 71:730\u2013737","journal-title":"Kidney Int"},{"key":"142_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(12)80446-X","volume":"19","author":"JA Delmez","year":"1992","unstructured":"Delmez JA, Slatopolsky E (1992) Hyperphosphatemia: its cones-quences and treatment in patients with chronic renal disease. Am J Kidney Dis 19:303\u2013317","journal-title":"Am J Kidney Dis"},{"key":"142_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-199607000-00006","volume":"5","author":"M Rodriguez","year":"1996","unstructured":"Rodriguez M, Almaden Y, Hernandez A, Torres A (1996) Effect of phosphate on the parathyroid gland: direct and indirect? Curr Opin Nephrol Hypertens 5:321\u2013328","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"142_CR18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI114043","volume":"83","author":"AA Portale","year":"1989","unstructured":"Portale AA, Halloran BP, Morris RC Jr (1989) Physiologic regulation of the serum concentration of 1,25-dihydroxy vitamin D by phosphorus in normal men. J Clin Invest 83:1494\u20131499","journal-title":"J Clin Invest"},{"key":"142_CR19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","volume":"11","author":"Y Almaden","year":"1996","unstructured":"Almaden Y, Canalejo A, Hernandez A et al (1996) Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11:970\u2013976","journal-title":"J Bone Miner Res"},{"key":"142_CR20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","volume":"11","author":"PK Nielsen","year":"1996","unstructured":"Nielsen PK, Feldt-Rasmussen U, Olgaard K (1996) A direct effect in vitro of phosphate on PTH release from bovine parathroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11:1762\u20131768","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","volume":"273","author":"E Moallem","year":"1998","unstructured":"Moallem E, Kilav R, Silver J, Naveh-Many T (1998) RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273:5253\u20135259","journal-title":"J Biol Chem"},{"key":"142_CR22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.1997.1420959.x","volume":"46","author":"Q Wang","year":"1997","unstructured":"Wang Q, Palnitkar S, Parfitt AM (1997) Parathyroid cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism. Clin Endocrinol 46:343\u2013349","journal-title":"Clin Endocrinol"},{"key":"142_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1523-1755.2001.059003855.x","volume":"59","author":"AS Dusso","year":"2001","unstructured":"Dusso AS, Pavlopoulos T, Naumovich L et al (2001) p21waf1 and TGF-\u03b1 mediate dietary phosphate-regulation of parathyroid cell growth. Kidney Int 59:855\u2013865","journal-title":"Kidney Int"},{"key":"142_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/cbir.1995.1083","volume":"19","author":"V Kumar","year":"1995","unstructured":"Kumar V, Bustiin SA, McKay IA (1995) Transforming growth factor alpha. Cell Biol Int 19:373\u2013388","journal-title":"Cell Biol Int"},{"key":"142_CR25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","volume":"60","author":"M Cozzolino","year":"2001","unstructured":"Cozzolino M, Lu Y, Finch J et al (2001) p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60:2109\u20132117","journal-title":"Kidney Int"},{"key":"142_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(89)90252-3","volume":"56","author":"ST Wong","year":"1989","unstructured":"Wong ST, Winchell LF, McCune BK et al (1989) The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56:495\u2013500","journal-title":"Cell"},{"key":"142_CR27","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/oxfordjournals.ndt.a027131","volume":"11","author":"J Gogusev","year":"1996","unstructured":"Gogusev J, Duchambon P, Soermann-Chopard C et al (1996) De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 11:2155\u20132162","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s002689900112","volume":"20","author":"GP Sadler","year":"1996","unstructured":"Sadler GP, Morgan JM, Jasani B et al (1996) Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and in situ hybridization study. World J Surg 20:736\u2013743","journal-title":"World J Surg"},{"key":"142_CR29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jsbmb.2004.03.061","volume":"89\u201390","author":"A Dusso","year":"2004","unstructured":"Dusso A, Cozzolino M, Lu Y et al (2004) 1,25-Dihydroxy vitamin D downregulation of TGF alpha\/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure. J Steroid Biochem Mol Biol 89\u201390:507\u2013511","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"142_CR30","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00167.2005","volume":"289","author":"M Cozzolino","year":"2005","unstructured":"Cozzolino M, Lu Y, Sato T et al (2005) A critical role for enhanced-TGF alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental renal disease. Am J Physiol Renal Physiol 289(5):F1096\u2013F1102","journal-title":"Am J Physiol Renal Physiol"},{"key":"142_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"issue":"12","key":"142_CR32","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"key":"142_CR33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2215\/CJN.05130610","volume":"6","author":"KJ Martin","year":"2011","unstructured":"Martin KJ, Gonz\u00e0lez EA (2011) Prevention and control of phosphate retention\/hyperphosphatemia in CKD-MBD: what Is normal, when to start, and how to treat? Clin J Am Soc Nephrol 6:440\u2013446","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"142_CR34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1523-1755.2005.00421.x","volume":"68","author":"M Cozzolino","year":"2005","unstructured":"Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E (2005) Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68(2):429\u2013436","journal-title":"Kidney Int"},{"issue":"4","key":"142_CR35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000209249","volume":"27","author":"PG Messa","year":"2009","unstructured":"Messa PG, Cerutti R, Brezzi B et al (2009) Calcium and phosphate control by dialysis treatments. Blood Purif 27(4):360\u2013368","journal-title":"Blood Purif"},{"issue":"4","key":"142_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000209246","volume":"27","author":"M Cozzolino","year":"2009","unstructured":"Cozzolino M, Ciceri P, Volpi EM et al (2009) Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease. Blood Purif 27(4):338\u2013344","journal-title":"Blood Purif"},{"key":"142_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000111827","volume":"28","author":"M Cozzolino","year":"2008","unstructured":"Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D (2008) Vascular calcification and uremia: what do we know? Am J Nephrol 28:339\u2013346","journal-title":"Am J Nephrol"},{"issue":"4","key":"142_CR38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000232941","volume":"28","author":"T Wei","year":"2009","unstructured":"Wei T, Wang M, Wang M, Gan LY, Li X (2009) Relationship of sRANKL level and vascular calcification score to cardiovascular events in maintenance hemodialysis patients. Blood Purif 28(4):342\u2013345","journal-title":"Blood Purif"},{"key":"142_CR39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000232942","volume":"28","author":"M Cozzolino","year":"2009","unstructured":"Cozzolino M (2009) Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kB in the vascular system. Blood Purif 28:346\u2013347","journal-title":"Blood Purif"},{"key":"142_CR40","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10\u2013E17","journal-title":"Circ Res"},{"key":"142_CR41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V et al (1997) Osf2\/Cbfa1 a transcriptional activator of osteoblast differentiation. Cell 89:747\u2013754","journal-title":"Cell"},{"key":"142_CR42","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","volume":"62","author":"NX Chen","year":"2002","unstructured":"Chen NX, O\u2019Neill KD, Duan D, Moe SM (2002) Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 62:1724\u20131731","journal-title":"Kidney Int"},{"key":"142_CR43","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","volume":"63","author":"SM Moe","year":"2003","unstructured":"Moe SM, Duan D, Doehle BP et al (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003\u20131011","journal-title":"Kidney Int"},{"key":"142_CR44","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/ndt\/gfh891","volume":"20","author":"AY Wang","year":"2005","unstructured":"Wang AY, Lam CW, Wang M et al (2005) Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 20:1676\u20131685","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"142_CR45","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/ndt\/gfl395","volume":"21","author":"A Galassi","year":"2006","unstructured":"Galassi A, Spiegel DM, Bellasi A et al (2006) Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transplant 21(11):3215\u20133222","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10157-003-0260-0","volume":"8","author":"M Matsuoka","year":"2004","unstructured":"Matsuoka M, Iseki K, Tamashiro M et al (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8:54\u201358","journal-title":"Clin Exp Nephrol"},{"key":"142_CR47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","volume":"71","author":"GA Block","year":"2007","unstructured":"Block GA, Raggi P, Bellasi A et al (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438\u2013441","journal-title":"Kidney Int"},{"key":"142_CR48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B et al (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938\u2013942","journal-title":"Hypertension"},{"key":"142_CR49","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gfh217","volume":"19","author":"T Adragao","year":"2004","unstructured":"Adragao T, Pires A, Lucas C et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Tranplant 19:1480\u20131488","journal-title":"Nephrol Dial Tranplant"},{"issue":"1","key":"142_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Wang M, Woo J et al (2003) Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14(1):159\u2013168","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"142_CR51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","volume":"7","author":"B Iorio di","year":"2012","unstructured":"di Iorio B, Bellasi A, Russo D (2012) Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 7(3):487\u2013493","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"142_CR52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","volume":"62","author":"B Iorio di","year":"2013","unstructured":"di Iorio B, Moloni D, Bell C et al (2013) Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis 62(4):771\u2013778","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"142_CR53","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","volume":"72","author":"WN Suki","year":"2007","unstructured":"Suki WN, Zabaneh R, Cangiano JL et al (2007) Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72(9):1130\u20131137","journal-title":"Kidney Int"},{"issue":"4","key":"142_CR54","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU et al (2011) The advance study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26(4):1327\u20131339","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR55","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P et al (2013) Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382:1268\u20131277","journal-title":"Lancet"},{"issue":"26","key":"142_CR56","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"GM Chertow","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367(26):2482\u20132494","journal-title":"N Engl J Med"},{"issue":"6","key":"142_CR57","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/sdi.12132","volume":"26","author":"M Aparicio","year":"2013","unstructured":"Aparicio M, Bellizzi V, Chauveau P et al (2013) Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis atients? Semin Dial 26(6):714\u2013719","journal-title":"Semin Dial"},{"key":"142_CR58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MNH.0b013e32832b5094","volume":"18","author":"R Kumar","year":"2009","unstructured":"Kumar R (2009) Phosphate sensing. Curr Opin Nephrol Hypertens 18:281\u2013284","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"142_CR59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-139X.2008.00426.x","volume":"21","author":"JS Berns","year":"2008","unstructured":"Berns JS (2008) Niacin and related compounds for treating hyperphosphatemia in dialysis patients. Semin Dial 21:203\u2013205","journal-title":"Semin Dial"},{"issue":"2","key":"142_CR60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","volume":"6","author":"SM Moe","year":"2011","unstructured":"Moe SM, Zidehsarai MP, Chambers MA et al (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 6(2):257\u2013264","journal-title":"Clin J Am Soc Nephrol."},{"key":"142_CR61","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0002-8223(96)00331-8","volume":"96","author":"M Boaz","year":"1996","unstructured":"Boaz M, Smetana S (1996) Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake. J Am Diet Assoc 96:1268\u20131270","journal-title":"J Am Diet Assoc"},{"key":"142_CR62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","volume":"5","author":"N Noori","year":"2010","unstructured":"Noori N, Kalantar-Zadeh K, Kovesdy CP et al (2010) Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 5:683\u2013692","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"142_CR63","first-page":"278","volume":"28","author":"A Cupisti","year":"2011","unstructured":"Cupisti A, D\u2019Alessandro C (2011) The impact of known and unknown dietary components to phosphorus intake. G Ital Nefrol 28(3):278\u2013288","journal-title":"G Ital Nefrol"},{"key":"142_CR64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1631\/jzus.B0710640","volume":"9","author":"L Bohn","year":"2008","unstructured":"Bohn L, Meyer AS, Rasmussen SK (2008) Phytate: impact on environment and human nutrition\u2014A challenge for molecular breeding. J Zhejiang Univ Sci B 9:165\u2013191","journal-title":"J Zhejiang Univ Sci B"},{"issue":"2","key":"142_CR65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semnephrol.2012.12.018","volume":"33","author":"A Cupisti","year":"2013","unstructured":"Cupisti A, Kalantar-Zadeh K (2013) Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol 33(2):180\u2013190","journal-title":"Semin Nephrol"},{"key":"142_CR66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.jrn.2004.09.007","volume":"15","author":"G Barsotti","year":"2005","unstructured":"Barsotti G, Cupisti A (2005) The role of dietary phosphorus restriction in the conservative management of chronic renal disease. J Ren Nutr 15:189\u2013192","journal-title":"J Ren Nutr"},{"issue":"Suppl 2","key":"142_CR67","first-page":"45","volume":"22","author":"D Fouque","year":"2007","unstructured":"Fouque D, Vennegoor M, ter Wee P et al (2007) EBPG guideline on nutrition. Nephrol Dial Transplant 22(Suppl 2):45\u201387","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR68","first-page":"29","volume":"16","author":"A Cupisti","year":"2003","unstructured":"Cupisti A, Morelli E, D\u2019Alessandro C, Lupetti S, Barsotti G (2003) Phosphate control in chronic uremia: don\u2019t forget diet. J Nephrol 16:29\u201333","journal-title":"J Nephrol"},{"key":"142_CR69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Gutekunst L, Mehrotra R et al (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:519\u2013530","journal-title":"Clin J Am Soc Nephrol"},{"key":"142_CR70","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2009.01.269","volume":"54","author":"RA Sherman","year":"2009","unstructured":"Sherman RA, Mehta O (2009) Dietary phosphorus in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54:18\u201323","journal-title":"Am J Kidney Dis"},{"key":"142_CR71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.jrn.2010.06.021","volume":"21","author":"O Benini","year":"2011","unstructured":"Benini O, D\u2019Alessandro C, Gianfaldoni D, Cupisti A (2011) Extra-phosphate load from food additives in commonly eaten foods: a renal and insidious danger for renal patients. J Ren Nutr 21:303\u2013308","journal-title":"J Ren Nutr"},{"issue":"6","key":"142_CR72","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.jrn.2011.12.010","volume":"22","author":"A Cupisti","year":"2012","unstructured":"Cupisti A, Benini O, Ferretti V et al (2012) Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives. J Ren Nutr 22(6):533\u2013540","journal-title":"J Ren Nutr"},{"issue":"4","key":"142_CR73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.jrn.2012.12.003","volume":"23","author":"JB Le\u00f3n","year":"2013","unstructured":"Le\u00f3n JB, Sullivan CM, Sehgal AR (2013) The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores. J Ren Nutr. 23(4):265\u2013270","journal-title":"J Ren Nutr."},{"issue":"1","key":"142_CR74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.jrn.2013.09.003","volume":"24","author":"A Carrigan","year":"2014","unstructured":"Carrigan A, Klinger A, Choquette SS, Luzuriaga-McPherson A, Bell EK, Darnell B, Guti\u00e9rrez OM (2014) Contribution of food additives to sodium and phosphorus content of diets rich in processed foods. J Ren Nutr. 24(1):13\u201319","journal-title":"J Ren Nutr."},{"issue":"1","key":"142_CR75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","volume":"24","author":"JT Daugirdas","year":"2011","unstructured":"Daugirdas JT, Finn WF, Emmett M et al (2011) Frequent hemodialysis network trial group. The phosphate binder equivalent dose. Semin Dial 24(1):41\u201349","journal-title":"Semin Dial"},{"key":"142_CR76","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2010020221","volume":"21","author":"OM Guti\u00e9rrez","year":"2010","unstructured":"Guti\u00e9rrez OM, Anderson C, Isakova T (2010) Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 21:1953\u20131960","journal-title":"J Am Soc Nephrol"},{"key":"142_CR77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1051-2276(01)38751-4","volume":"11","author":"WL Jones","year":"2001","unstructured":"Jones WL (2001) Demineralization of a wide variety of foods for the renal patient. J Ren Nutr 11:90\u201396","journal-title":"J Ren Nutr"},{"key":"142_CR78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.jrn.2005.10.005","volume":"16","author":"A Cupisti","year":"2006","unstructured":"Cupisti A, Comar F, Benini O et al (2006) Effect of boiling on dietary phosphate and nitrogen intake. J Ren Nutr 16:36\u201340","journal-title":"J Ren Nutr"},{"issue":"6","key":"142_CR79","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.jrn.2011.11.003","volume":"22","author":"A Cupisti","year":"2012","unstructured":"Cupisti A, Ferretti V, D\u2019Alessandro C et al (2012) Nutritional knowledge in hemodialysis patients and nurses: focus on phosphorus. J Ren Nutr. 22(6):541\u2013546","journal-title":"J Ren Nutr."},{"key":"142_CR80","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","volume":"301","author":"C Sullivan","year":"2009","unstructured":"Sullivan C, Sayre SS, Leon JB et al (2009) Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 301:629\u2013635","journal-title":"JAMA"},{"issue":"4","key":"142_CR81","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.jrn.2010.11.006","volume":"21","author":"D Caldeira","year":"2011","unstructured":"Caldeira D, Amaral T, David C et al (2011) Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with meta-analysis. J Ren Nutr. 21(4):285\u2013294","journal-title":"J Ren Nutr."},{"issue":"5","key":"142_CR82","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ki.2013.258","volume":"84","author":"M Tonelli","year":"2013","unstructured":"Tonelli M (2013) Serum phosphorus in people with chronic kidney disease: you are what you eat. Kidney Int 84(5):871\u2013873","journal-title":"Kidney Int"},{"key":"142_CR83","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP et al (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771\u2013780","journal-title":"Kidney Int"},{"key":"142_CR84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000245640","volume":"29","author":"M Kuhlmann","year":"2010","unstructured":"Kuhlmann M (2010) Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif 29:137\u2013144","journal-title":"Blood Purif"},{"key":"142_CR85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000067866","volume":"21","author":"FA Gotch","year":"2003","unstructured":"Gotch FA, Panlilio F, Sergeyeva O et al (2003) A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 21:51\u201357","journal-title":"Blood Purif"},{"key":"142_CR86","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1523-1755.2005.09504.x","volume":"95","author":"SG Achinher","year":"2005","unstructured":"Achinher SG, Ayus JC (2005) The role of daily dialysis in the control of hyperphosphatemia. Kideny Int Suppl 95:S28\u2013S32","journal-title":"Kideny Int Suppl"},{"issue":"2","key":"142_CR87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1542-4758.2011.00538.x","volume":"15","author":"CM Kjellstrand","year":"2011","unstructured":"Kjellstrand CM, Ing TS, Kjellstrand PT et al (2011) Phosphorus dynamics during hemodialysis. Hemodial Int 15(2):226\u2013233","journal-title":"Hemodial Int"},{"key":"142_CR88","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","volume":"53","author":"I Mucsi","year":"1998","unstructured":"Mucsi I, Hercz G, Uldall R et al (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kideny Int 53:1399\u20131404","journal-title":"Kideny Int"},{"key":"142_CR89","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/ndt\/gfq724","volume":"26","author":"E Ok","year":"2011","unstructured":"Ok E, Duman S, Asci G et al (2011) Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-center haemodialysis. Nephrol Dial Transplant 26:1287\u20131296","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR90","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1341046","volume":"13","author":"R Minutolo","year":"2002","unstructured":"Minutolo R, Bellizzi V, Cioffi M et al (2002) Postdialytic rebound of serum phosphorus: pathogentic and clinical insights. J Am Soc Nephrol 13:1046\u20131054","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"142_CR91","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/ndt\/gfq761","volume":"26","author":"LA Pedrini","year":"2011","unstructured":"Pedrini LA, de Cristofaro V, Comelli M et al (2011) Long-term effects of high-efficiency of haemodialfiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 26(8):2617\u20132624","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"142_CR92","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1093\/ndt\/gfr179","volume":"26","author":"E Movilli","year":"2011","unstructured":"Movilli E, Camerini C, Gaggia P et al (2011) Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrol Dial Transplant 26(12):4032\u20134037","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"142_CR93","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ndt\/gfp560","volume":"25","author":"A Davenport","year":"2010","unstructured":"Davenport A, Gardner C, Delaney M et al (2010) The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The pan thames renal audit. Nephrol Dial Transplant 25(3):897\u2013901","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"142_CR94","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000322834","volume":"33","author":"T Oates","year":"2011","unstructured":"Oates T, Pinney JH, Davenport A (2011) Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol 33(1):70\u201375","journal-title":"Am J Nephrol"},{"issue":"1","key":"142_CR95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2009.09.023","volume":"55","author":"EL Penne","year":"2010","unstructured":"Penne EL, van der Weerd NC, van den Dorpel MA et al (2010) Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled convective transport study (contrast). Am J Kidney Dis 55(1):77\u201387","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"142_CR96","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/ndt\/gft396","volume":"28","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong P, Siribamrungwong M, Jaber BL (2013) Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 28(11):2859\u20132874","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"142_CR97","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1681\/ASN.2012080875","volume":"24","author":"F Maduell","year":"2013","unstructured":"Maduell F, Moreso F, Pons M et al (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24(3):487\u2013497","journal-title":"J Am Soc Nephrol"},{"key":"142_CR98","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ndt\/gfu031","volume":"29","author":"F Locatelli","year":"2014","unstructured":"Locatelli F, Altieri P, Andrulli S et al (2014) Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial. Nephrol Dial Transplant 29:1239\u20131246","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"142_CR99","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Guti\u00e9rrez OM, Chang Y et al (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20(2):388\u2013396","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"142_CR100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","volume":"72","author":"D Russo","year":"2007","unstructured":"Russo D, Miranda I, Ruocco C et al (2007) The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72(10):1255\u20131261","journal-title":"Kidney Int"},{"issue":"4","key":"142_CR101","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","volume":"68","author":"GA Block","year":"2005","unstructured":"Block GA, Spiegel DM, Ehrlich J et al (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68(4):1815\u20131824","journal-title":"Kidney Int"},{"issue":"3","key":"142_CR102","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1797.2010.01412.x","volume":"16","author":"ND Toussaint","year":"2011","unstructured":"Toussaint ND, Lau KK, Polkinghorne KR et al (2011) Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: a pilot randomized controlled trial. Nephrology (Carlton) 16(3):290\u2013298","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"142_CR103","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","volume":"4","author":"YW Chiu","year":"2009","unstructured":"Chiu YW, Teitelbaum I, Misra M et al (2009) Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 4(6):1089\u20131096","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"142_CR104","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.ajkd.2010.11.028","volume":"57","author":"P Martin","year":"2011","unstructured":"Martin P, Wang P, Robinson A et al (2011) Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study. Am J Kidney Dis 57(5):700\u2013706","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"142_CR105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CNP72252","volume":"72","author":"SM Sprague","year":"2009","unstructured":"Sprague SM, Ross EA, Nath SD et al (2009) Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study. Clin Nephrol 72(4):252\u2013258","journal-title":"Clin Nephrol"},{"issue":"3","key":"142_CR106","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.jrn.2010.04.007","volume":"21","author":"L Noto","year":"2011","unstructured":"Noto L (2011) Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders. J Renal Nutr 21(3):277\u2013289","journal-title":"J Renal Nutr"},{"issue":"4","key":"142_CR107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.jrn.2009.10.009","volume":"20","author":"WL Chan","year":"2010","unstructured":"Chan WL, Rounsley K, Chapman E et al (2010) Lanthanum carbonate is an effective hypophosphatemic agent for hemodialysis patients intolerant of other phosphate binders. J Renal Nutr 20(4):270\u2013277","journal-title":"J Renal Nutr"},{"key":"142_CR108","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1093\/ndt\/gfn310","volume":"23","author":"A Hutchinson","year":"2008","unstructured":"Hutchinson A, Laville M (2008) Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden. Nephrol Dial Transplant 23:3677\u20133684","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR109","first-page":"1147","volume":"7","author":"MJ Lloret","year":"2013","unstructured":"Lloret MJ, Ruiz-Garc\u00eda C, Dasilva I et al (2013) Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation\u2014safety, efficacy, and patient adherence. Patient Prefer Adherence 7:1147\u20131156","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"142_CR110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1753944713513061","volume":"7","author":"A Rastogi","year":"2013","unstructured":"Rastogi A (2013) Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Ther Adv Cardiovasc Dis 7(6):322\u2013342","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"142_CR111","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/ndt\/gfq292","volume":"25","author":"ALM Francisco de","year":"2010","unstructured":"de Francisco ALM, Leidig M, Covic AC et al (2010) Evaluation of calcium acetate\/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 25:3707\u20133717","journal-title":"Nephrol Dial Transplant"},{"key":"142_CR112","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/ndt\/gft203","volume":"28","author":"A Covic","year":"2013","unstructured":"Covic A, Passlick-Deetjen J, Kroczak M et al (2013) A comparison of calcium acetate\/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled randomized study. Nephrol Dial Transplant 28:2383\u20132392","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"142_CR113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ckj\/sfu011","volume":"7","author":"A Galassi","year":"2014","unstructured":"Galassi A, Cozzolino M (2014) Magnesium: a renewed player of vascular aging in diabetic CKD patients? Clin Kidney J 7(2):93\u201396","journal-title":"Clin Kidney J"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0142-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0142-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:19Z","timestamp":1777564699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/28\/4\/415\/8372332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0142-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]}}}